AKT kinase pathway: a leading target in cancer research.
Kumar, Ambuj, Vidya Rajendran, Rao Sethumadhavan, and Rituraj Purohit. 2013. “AKT Kinase Pathway: A Leading Target in Cancer Research.”. TheScientificWorldJournal 2013: 756134.
Search
Search results
1934 results found
Resident duty hours and resident and patient outcomes: Systematic review and meta-analysis.
Sephien, Andrew, Tea Reljic, Jeffrey Jordan, Xavier Prida, and Ambuj Kumar. 2023. “Resident Duty Hours and Resident and Patient Outcomes: Systematic Review and Meta-Analysis.”. Medical Education 57 (3): 221-32.
Optimism bias leads to inconclusive results-an empirical study.
Djulbegovic, Benjamin, Ambuj Kumar, Anja Magazin, Anneke T Schroen, Heloisa Soares, Iztok Hozo, Mike Clarke, Daniel Sargent, and Michael J Schell. 2011. “Optimism Bias Leads to Inconclusive Results-an Empirical Study.”. Journal of Clinical Epidemiology 64 (6): 583-93.
Effective arteriovenous fistula alternative for hemodialysis access.
Buggs, Jacentha, Adam Tanious, Victor Camba, Christopher Albertson, Ebonie Rogers, Dylan Lahiff, Talha Rashid, et al. 2018. “Effective Arteriovenous Fistula Alternative for Hemodialysis Access.”. American Journal of Surgery 216 (6): 1144-47.
Bedaquiline versus placebo for management of multiple drug-resistant tuberculosis: A systematic review.
Charan, Jaykaran, Tea Reljic, and Ambuj Kumar. 2016. “Bedaquiline versus Placebo for Management of Multiple Drug-Resistant Tuberculosis: A Systematic Review.”. Indian Journal of Pharmacology 48 (2): 186-91.
Treatment-related harms: what was planned and what was reported? National Cancer Institute's Co-operative group phase III randomized controlled trials: a systematic review.
Mhaskar, Rahul S, Tea Reljic, Hesborn Wao, Ambuj Kumar, Branko Miladinovic, and Benjamin Djulbegovic. 2014. “Treatment-Related Harms: What Was Planned and What Was Reported? National Cancer Institute’s Co-Operative Group Phase III Randomized Controlled Trials: A Systematic Review.”. Journal of Clinical Epidemiology 67 (3): 354-6.
Letter to the Editor: Beta-blocker therapy.
Kumar, Ambuj, Amandeep Kumar, Pankaj Kumar Singh, Shashwat Mishra, Kanwaljeet Garg, and Bhawani S Sharma. 2017. “Letter to the Editor: Beta-Blocker Therapy.”. Journal of Neurosurgery 126 (3): 1026-27.
Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis.
Wao, Hesborn, Rahul Mhaskar, Ambuj Kumar, Branko Miladinovic, and Benjamin Djulbegovic. 2013. “Survival of Patients With Non-Small Cell Lung Cancer Without Treatment: A Systematic Review and Meta-Analysis.”. Systematic Reviews 2: 10.
Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review.
Mhaskar, Rahul, Ambuj Kumar, Madhusmita Behera, Mohamed A Kharfan-Dabaja, and Benjamin Djulbegovic. 2009. “Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review.”. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 15 (8): 893-902.
Comparison of methodological quality of positive versus negative comparative studies published in Indian medical journals: a systematic review.
Charan, Jaykaran, Mayur Chaudhari, Ryan Jackson, Rahul Mhaskar, Tea Reljic, and Ambuj Kumar. 2015. “Comparison of Methodological Quality of Positive versus Negative Comparative Studies Published in Indian Medical Journals: A Systematic Review.”. BMJ Open 5 (6): e007853.